Sun Pharma Advanced Research Company Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
SPARC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SPARC has informed the stock exchanges that its trading window will remain closed for insiders starting October 1, 2025. The window will stay shut until 48 hours after the company declares its unaudited financial results for the second quarter and half year ended September 30, 2025. The board meeting date to approve these Q2 results will be communicated separately. This is a standard compliance filing under SEBI's Prohibition of Insider Trading Regulations to prevent insider trading ahead of the earnings announcement.
No direct impact on shareholders. The trading window closure means insiders, promoters, and designated employees cannot trade in SPARC shares until results are announced plus 48 hours. Investors should wait for the Q2 results announcement for any fundamental updates on the company.